Fund Holdings — Yiheng Capital Management, L.P.

Total Portfolio Value
$229.31M
Total Bought
$10.34M
Total Sold
$86.72M
Net Transaction
-$76.38M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
DBV TECHNOLOGIES S A(DBVT)656,309639,769-16,5406,56312,2645.35%+5,701
PONY AI INC(PONY)200,300653,215+452,9154,5059,4724.13%+4,967
FULL TRUCK ALLIANCE CO LTD(YMM)0411,143+411,14304,4121.92%+4,412
ATRENEW INC(RERE)3,163,1173,163,117014,55016,7657.31%+2,214
H WORLD GROUP LTD(HTHT)457,032398,371-58,66117,87518,7438.17%+869
YATSEN HLDG LTD(YSG)96,328368,347+272,0198731,4330.62%+560
PASSAGE BIO INC(PASG)034,301+34,30104050.18%+405
AGORA INC(API)533,547533,54702,0382,1720.95%+133
GENERATION BIO CO105,524105,52406465990.26%-46
TAL EDUCATION GROUP(TAL)309,240309,24003,4633,3741.47%-90
TUNIU CORP(TOUR)314,437314,43702991950.09%-104
BEAM THERAPEUTICS INC(BEAM)69,05821,126-47,9321,6765860.26%-1,090
KYMERA THERAPEUTICS INC(KYMR)122,60573,440-49,1656,9395,7142.49%-1,225
SILVACO GROUP INC(SVCO)1,096,2821,096,28205,9314,4401.94%-1,491
ACM RESH INC(ACMR)280,201174,447-105,75410,9646,8823.00%-4,082
CELLEBRITE DI LTD(CLBT)231,0310-231,0314,2810—-4,281
VIRIDIAN THERAPEUTICS INC(VRDN)500,261208,735-291,52610,7966,4962.83%-4,300
ULTRAGENYX PHARMACEUTICAL IN(RARE)225,7580-225,7586,7910—-6,791
DENALI THERAPEUTICS INC(DNLI)469,9810-469,9816,8240—-6,824
JD.COM INC(JD)787,413687,413-100,00027,54419,7298.60%-7,815
NEW ORIENTAL ED & TECHNOLOGY(EDU)521,901340,629-181,27227,69718,7458.17%-8,952
AKERO THERAPEUTICS INC191,0760-191,0769,0720—-9,072
NOAH HLDGS LTD(NOAH)6,717,3516,717,351077,85467,44229.41%-10,412
BILIBILI INC1,418,5641,148,898-269,66639,84728,25112.32%-11,596
INVENTIVA SA(IVA)2,644,926255,915-2,389,01115,3141,1900.52%-14,124
Page 1 of 1
Yiheng Capital Management, L.P. — 13F Holdings — Q4 2025 | TickerTrail